Hörnquist E, Grdic D, Mak T, Lycke N
Department of Medical Microbiology and Immunology, University of Göteborg, Sweden.
Immunology. 1996 Feb;87(2):220-9. doi: 10.1046/j.1365-2567.1996.473536.x.
We used normal, CD4 and CD8 gene-targeted mice to investigate the role of CD4+ and CD8+ T cells in the regulation of gut mucosal immune responses following oral immunizations with cholera toxin (CT) adjuvant. Phenotypic analysis of mucosa-associated tissues revealed normal CD3+ T-cell frequencies in CD4-/- and CD8-/- mice such that in CD4-/- mice the CD8+ and double-negative (DN) T cells were increased. In CD8-/- mice the CD4+ T cells were increased, with the exception that in the intraepithelial compartment the CD3+ T cells were predominantly DN gamma delta T-cell receptor (TCR)+ T cells. All mice, normal and deficient, failed to respond to oral immunization with the antigen, keyhole limpet haemocyanin (KLH), alone. In the presence of CT adjuvant, however, CD8-/- mice consistently exhibited three- to fivefold stronger gut mucosal responses compared to normal C57B1/6 mice. By contrast, no difference was observed for systemic responses between CD8-/- and normal mice. Thus the up-regulation selectively affected mucosal responses, suggesting that, contrary to the CD8-/- mouse gut, the normal gut mucosa may host CD8+ T cells that exert a local suppressive effect on T- and B-cell responses. The magnitude of the enhancing effect of CT was comparable in CD8-/- and normal mice, clearly demonstrating that the adjuvant mechanism of CT does not require CD8+ T cells. On the other hand, the adjuvant effect of CT required CD4+ T cells, because no or poor anti-KLH responses were observed in CD4-/- mice. In both normal and CD8-/- mice CT adjuvant promoted KLH-specific CD4+ T-cell printing without any selective effect on the differentiation towards a T-helper type-1 (Th1) or Th2 dominance. Furthermore, CT adjuvant increased the frequency of CD4+ T cells expressing a memory phenotype, i.e. CD44high, LECAM-1low and CD45RBlow. We have shown, using gene-targeted mice, that CD8+ T cells are not required for the adjuvant effect of CT, and that CD8+ T cells may exert local mucosal down-regulation of intestinal immune responses.
我们使用正常小鼠、CD4基因敲除小鼠和CD8基因敲除小鼠,来研究CD4⁺和CD8⁺ T细胞在霍乱毒素(CT)佐剂口服免疫后肠道黏膜免疫反应调节中的作用。对黏膜相关组织的表型分析显示,CD4⁻/⁻和CD8⁻/⁻小鼠中CD3⁺ T细胞频率正常,因此在CD4⁻/⁻小鼠中,CD8⁺和双阴性(DN)T细胞增加。在CD8⁻/⁻小鼠中,CD4⁺ T细胞增加,但上皮内区室中的CD3⁺ T细胞主要是DN γδ T细胞受体(TCR)⁺ T细胞。所有正常和缺陷小鼠单独口服抗原钥孔戚血蓝蛋白(KLH)均无反应。然而,在CT佐剂存在的情况下,与正常C57B1/6小鼠相比,CD8⁻/⁻小鼠始终表现出强三到五倍的肠道黏膜反应。相比之下,CD8⁻/⁻小鼠和正常小鼠的全身反应没有差异。因此,上调选择性地影响黏膜反应,这表明与CD8⁻/⁻小鼠肠道相反,正常肠道黏膜可能存在对T细胞和B细胞反应具有局部抑制作用的CD8⁺ T细胞。CT的增强作用幅度在CD8⁻/⁻小鼠和正常小鼠中相当,清楚地表明CT的佐剂机制不需要CD8⁺ T细胞。另一方面,CT的佐剂作用需要CD4⁺ T细胞,因为在CD4⁻/⁻小鼠中未观察到或仅有较弱的抗KLH反应。在正常和CD8⁻/⁻小鼠中,CT佐剂均促进KLH特异性CD4⁺ T细胞增殖,且对向1型辅助性T细胞(Th1)或Th2优势分化没有任何选择性影响。此外,CT佐剂增加了表达记忆表型(即CD44高、LECAM-1低和CD45RB低)的CD4⁺ T细胞频率。我们使用基因敲除小鼠表明,CT的佐剂作用不需要CD8⁺ T细胞,并且CD8⁺ T细胞可能对肠道免疫反应发挥局部黏膜下调作用。